TY - JOUR
T1 - Strategies to simplify complex medication regimens
AU - Bell, J. Simon
AU - McInerney, Brigid
AU - Chen, Esa Y.H.
AU - Bergen, Phillip J.
AU - Reynolds, Lorenna
AU - Sluggett, Janet K.
N1 - Funding Information:
J Simon Bell BPharm (Hons), PhD, Professor and Director, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Vic. Brigid McInerney BPharm, GradCertPharmPrac, MClinPharm, AACP, Senior Pharmacist, Community Care Services, Alfred Health, Vic Esa YH Chen BPharm (Hons), Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Vic Phillip J Bergen BSc, BPharm (Hons), GCAP, MTeach (Sec), PhD, Senior Research Officer, Microbiology, School of Biomedical Sciences, Monash University, Vic; Adjunct Research Fellow, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Vic Lorenna Reynolds BPharm (Hons), GradCertPharmPracInt, Research Officer, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Vic Janet K Sluggett BPharm (Hons), GradDipClinEpid, PhD, FSHP, AACPA, Senior Research Fellow, UniSA Allied Health and Human Performance, University of South Australia, SA; Adjunct Research Fellow, Centre for Medicine Use and Safety, Monash University, Vic Competing interests: JSB reports grants from the National Health and Medical Research Council (NHMRC) Cognitive Decline Partnership Centre, the NHMRC Boosting Dementia Leadership Fellowship, the Victorian Government Department of Health and Human Services, Dementia Australia Research Foundation, GlaxoSmithKline and several aged care provider organisations, outside the submitted work. EYHC is supported by postgraduate research scholarships from the NHMRC Cognitive Decline Partnership Centre and the Faculty of Pharmacy and Pharmaceutical Sciences (Monash University). LR is partly funded through the NHMRC Boosting Dementia Scheme. JKS is supported by an NHMRC Early Career Fellowship (grant number APP1156439). Funding: The manuscript was prepared with funding support provided by the National Health and Medical Research Council (NHMRC) Cognitive Decline Partnership Centre. Provenance and peer review: Not commissioned, externally peer reviewed. Correspondence to: [email protected] 1. Trevena L. Minimally disruptive medicine for patients with complex multimorbidity. Aust J Gen Pract 2018;47(4):175–79. doi: 10.31128/AFP-10-17-4374.
Publisher Copyright:
© The Royal Australian College of General Practitioners 2021.
PY - 2021/1
Y1 - 2021/1
N2 - Background Older people use increasingly complex medication regimens. Complex regimens are challenging to administer, particularly for those with cognitive impairment, frailty, poor eyesight or limited dexterity. Complex regimens have been linked to non-adherence, medication errors and hospital admissions. Objective The aim of this article is to describe strategies to reduce the complexity of medication regimens in community and residential aged care settings. Discussion Medication regimen simplification is the process of reducing medication burden through strategies such as consolidating dosing times, standardising routes of administration, using long-acting rather than shorter-acting formulations, and switching to combination products in place of single-ingredient products. Obtaining a best possible medication history, ensuring appropriateness of current therapy, and deprescribing are important steps prior to implementing regimen simplification. Implementing such strategies should be based on a discussion and consideration of patient preferences, and include clinical judgement to limit the risk of unintended consequences for patients or carers.
AB - Background Older people use increasingly complex medication regimens. Complex regimens are challenging to administer, particularly for those with cognitive impairment, frailty, poor eyesight or limited dexterity. Complex regimens have been linked to non-adherence, medication errors and hospital admissions. Objective The aim of this article is to describe strategies to reduce the complexity of medication regimens in community and residential aged care settings. Discussion Medication regimen simplification is the process of reducing medication burden through strategies such as consolidating dosing times, standardising routes of administration, using long-acting rather than shorter-acting formulations, and switching to combination products in place of single-ingredient products. Obtaining a best possible medication history, ensuring appropriateness of current therapy, and deprescribing are important steps prior to implementing regimen simplification. Implementing such strategies should be based on a discussion and consideration of patient preferences, and include clinical judgement to limit the risk of unintended consequences for patients or carers.
UR - http://www.scopus.com/inward/record.url?scp=85101039222&partnerID=8YFLogxK
U2 - 10.31128/AJGP-04-20-5322
DO - 10.31128/AJGP-04-20-5322
M3 - Article
C2 - 33543163
AN - SCOPUS:85101039222
SN - 2208-794X
VL - 50
SP - 43
EP - 48
JO - Australian Journal of General Practice
JF - Australian Journal of General Practice
IS - 1-2
ER -